Connect your AI

Imax IMAX Payments Of Debt Issuance Costs Related To Convertible Notes

Payments Of Debt Issuance Costs Related To Convertible Notes at other companies

BioCryst PharmaceuticalsBCRX

$4.95M—

TidewaterTDW

$101K-98.0%

HWK

HawkinsHWKN

$764K—

ADMA BiologicsADMA

$559.25K—

Virtu FinancialVIRT

$0-100%

V2XVVX

$0-100%

Other financials

Income statement

Revenue$81.4M-6.1%

Gross profit$45.8M-13.9%

Operating income$10.0M-40.5%

Net income$4.2M+81.6%

EPS (diluted)$0.07+75.0%

Balance sheet

Cash & equivalents$146.0M+50.4%

Total debt$11.1M-6.7%

Total equity$335.5M+12.0%

Total assets$893.2M+5.3%

Cash flow

Operating cash flow$4.0M-42.0%

CapEx$2.1M+29.6%

Free cash flow$1.9M-64.2%

Valuation

Market cap$2.47B+46.9%

P/E67.3×+0.2×

P/S6.1×+1.4×

Profitability

Gross margin59%+4.4pp

Operating margin19.1%+5.6pp

Net margin9.1%+2.1pp

FCF margin28.5%+6.3pp

Returns & leverage

Return on equity11.6%+2.6pp

Debt / equity0×0.0×

Where this comes from

Reported directly by Imax in its filing.

Tagged under the XBRL concept imax:PaymentsOfDebtIssuanceCostsRelatedToConvertibleNotes.

The official record: Imax’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Imax's payments of debt issuance costs related to convertible notes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Imax's payments of debt issuance costs related to convertible notes?: Imax (IMAX) reported payments of debt issuance costs related to convertible notes of $944K in Q1 2026.
What does payments of debt issuance costs related to convertible notes mean?: Captures the direct costs, such as legal, accounting, and underwriting fees, incurred to issue or refinance convertible debt instruments. These costs are capitalized and amortized over the life of the debt. Monitoring these payments provides insight into the cost of accessing capital markets and the efficiency of debt financing activities.